simplex 1 (HSV-1), herpes simplex 2 (HSV-2), varicella zoster virus (VZV), human cytomegalovirus (HCMV), Epstein–Barr virus (EBV ), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma –associated herpesvirus. Al...
Herpesvirus 6Human疱疹病毒科感染疱疹病毒6型人Human herpesvirus 6 (HHV-6), a member of the 尾-herpesvirinae subfamily, is highly seroprevalent, has a worldwide distribution, and infection usually occurs within the first two years of life. In this age group, HHV-6 causes febrile illness ...
This will likely continue to improve the rate of causative agent identification in seemingly idiopathic viral meningitis, including this case of human herpesvirus 6 (HHV-6) meningitis in an immunocompetent adult patient. More common viral etiologies need to be excluded before diagnosing HHV-6 ...
Human herpesvirus 6 (HHV-6) is a herpesvirus that causes roseola infantum (or exanthema subitum [sixth disease]) in infants and children. [1, 2] Infection is nearly ubiquitous by age 2 years. [3] Management of HHV-6 infection in immunocompetent hosts is supportive. [4] HHV-6 infection...
Human herpes virus-6 (HHV-6) is a γherpesvirusclosely related to HHV-7 (Caserta and Hall, 1998). HHV-6 infects infants between the ages of 6 to 24 months, with a small percentage developing roseola infantum (Dockrell et al., 1999). HHV-6 causes disease in immunocompromised hosts, su...
(1996) Human herpesvirus 6 in human immuno- deficiency virus-infected individuals: association with early his- tologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders. Journal of Medical Viro- logy, 48, 344-353....
In infants with signs and symptoms of classic roseola infantum, human herpesvirus 6 (HHV-6) can be the causative agent. However, since this diagnosis has various differential diagnoses, other causes for fever and rash should be excluded. In immunocompetent adults with symptomatic HHV-6 disease,...
CAR T-cell therapy Human herpesvirus-6 Myelitis Introduction While primary infection with human herpesvirus 6 (HHV-6) presents clinically as roseola in childhood, disease in immunocompromised persons may occur through reactivation after genomic integration, with most cases reported after haematopoietic stem...
Human herpesvirus 6 infects virtually all children within the first few years of life and like other herpesviruses, establishes latency after primary infection. In immunocompromised hosts, especially hematopoietic cell transplant (HCT) recipients, HHV-6 has been demonstrated to reactivate frequently. This...
Human herpesvirus 6 infects virtually all children within the first few years of life and like other herpesviruses, establishes latency after primary infection. In immunocompromised hosts, especially hematopoietic cell transplant (HCT) recipients, HHV-6 has been demonstrated to reactivate frequently. This...